Mike Walther serves as our President. Prior to Prometheus, Mike was most recently General Manager of Aries Pharmaceuticals having joined in 2017 to help establish the startup capabilities, commercial strategy and launch of the company’s pharmaceutical and medical device portfolio of specialty gastroenterology products. Prior to Aries, Mike was with Prometheus, a Nestlé Health Science company, in a series of leadership roles across the company’s therapeutic and diagnostic businesses, concluding as Vice President of Commercial Development. Earlier in his career, Mike spent nearly two decades at Takeda Pharmaceuticals North America and TAP Pharmaceuticals (a Takeda and Abbott Laboratories joint venture) in key roles of increasing responsibility spanning Marketing, Sales, Market Access and Commercial Operations. Mike holds a BA in Biology from Ithaca College.
